Engineering formulation-ready active pharmaceutical ingredients: myth or reality?

被引:0
|
作者
Marziano, I. [1 ]
机构
[1] Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:A91 / A92
页数:2
相关论文
共 50 条
  • [1] Amorphization of crystalline active pharmaceutical ingredients via formulation technologies
    Lim, Ron Tau Yee
    Ong, Chin Kheng
    Cheng, Shuying
    Ng, Wai Kiong
    [J]. POWDER TECHNOLOGY, 2017, 311 : 175 - 184
  • [2] Photoinstability in active pharmaceutical ingredients: Crystal engineering as a mitigating measure
    SeethaLekshmi, Sunil
    Thakur, Tejender S.
    Varughese, Sunil
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS, 2021, 49
  • [3] Developed and Validated for the Estimation of Tapinarof in Topical Formulation and Active Pharmaceutical Ingredients
    Reddy, C. Raghunatha
    Gosu, Nageswara Reddy
    [J]. JOURNAL OF AOAC INTERNATIONAL, 2024, 107 (01) : 46 - 51
  • [4] Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients
    Vishweshwar, P
    McMahon, JA
    Peterson, ML
    Hickey, MB
    Shattock, TR
    Zaworotko, MJ
    [J]. CHEMICAL COMMUNICATIONS, 2005, (36) : 4601 - 4603
  • [5] Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
    Blagden, N.
    de Matas, M.
    Gavan, P. T.
    York, P.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 617 - 630
  • [6] Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges
    Kaialy, Waseem
    Al Shafiee, Maen
    [J]. ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2016, 228 : 71 - 91
  • [7] Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach
    Juhnke, Michael
    Berghausen, Joerg
    Timpe, Carsten
    [J]. CHEMICAL ENGINEERING & TECHNOLOGY, 2010, 33 (09) : 1412 - 1418
  • [8] An industrial and chemical engineering perspective on the formulation of active ingredients in pharmaceuticals and agrochemicals
    ten Kate, Antoon J. B.
    Piccione, Patrick M.
    Westbye, Peter
    Becker, Antonio F. Amado
    [J]. CURRENT OPINION IN CHEMICAL ENGINEERING, 2022, 36
  • [9] Polymorphism of active pharmaceutical ingredients
    Karpinski, PH
    [J]. CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) : 233 - 237
  • [10] Prequalification of active pharmaceutical ingredients
    [J]. WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37